ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
63.987,20
0,91%
Brent Oil
88,165
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. T2 Biosystems Inc (TTOO)

  7. T2 Biosystems Inc (TTOO) Notícias

TTOO T2 Biosystems Inc

2,81
0,07 (2,55%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
T2 Biosystems Inc TTOO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,07 2,55% 2,81 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,76 2,7001 2,9353 2,84 2,74
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/04/202410:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
11/04/202417:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
28/03/202410:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
20/03/202408:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
19/03/202410:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
18/03/202410:00GLOBET2 Biosystems Announces New Publication Highlighting the..
12/03/202410:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
15/02/202418:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
15/02/202418:04GLOBET2 Biosystems Announces Agreement with CRG for the..
15/02/202418:02GLOBET2 Biosystems Announces Commercial Expansion Through..
12/02/202411:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the Expanded..
07/02/202418:05GLOBET2 Biosystems to Report Fourth Quarter and Full Year 2023..
18/01/202411:00GLOBET2 Biosystems Announces Participation in NIH-funded..
03/01/202411:00GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand Use..
03/11/202310:00GLOBET2 Biosystems to Participate in the Canaccord Genuity..
01/11/202310:00GLOBET2 Biosystems Regains Compliance with Nasdaq Listing..
24/10/202317:05GLOBET2 Biosystems Highlights New Clinical Data Presented at..
23/10/202310:00GLOBET2 Biosystems Announces Amendment and Extension of CRG Term..
12/10/202317:05GLOBET2 Biosystems Announces Preliminary Third Quarter 2023..
12/10/202317:02GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand the..
12/10/202310:00GLOBET2 Biosystems Announces Reverse Stock Split Effective Today
06/10/202317:07GLOBET2 Biosystems Reports Granting of Inducement Award
05/10/202317:05GLOBET2 Biosystems to Report Preliminary Third Quarter 2023..
19/09/202310:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the..
15/09/202317:05GLOBET2 Biosystems Reports Granting of Inducement Award
07/09/202317:05GLOBET2 Biosystems to Participate in the Gilmartin Group Emerging..
28/08/202309:30GLOBET2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S...
09/08/202309:30GLOBET2 Biosystems Regains Compliance with Nasdaq’s Market Value..
07/08/202317:05GLOBET2 Biosystems Announces Second Quarter 2023 Financial..
31/07/202309:30GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
28/07/202309:30GLOBET2 Biosystems to Attend Upcoming Investor Conferences
24/07/202317:05GLOBET2 Biosystems to Report Second Quarter 2023 Financial..
21/07/202317:05GLOBET2 Biosystems Reports Granting of Inducement Award
20/07/202309:30GLOBET2 Biosystems Receives FDA Breakthrough Device Designation..
12/07/202309:30GLOBET2 Biosystems Announces Preliminary Second Quarter 2023..
06/07/202309:00GLOBET2 Biosystems Announces Conversion of Approximately Twenty..
09/06/202310:15GLOBET2 Biosystems Announces Clinical Collaboration with..
05/06/202310:00GLOBET2 Biosystems Announces Submission for FDA Breakthrough..
30/05/202310:00GLOBET2 Biosystems Announces Second Largest Sepsis-Driven..
23/05/202309:05GLOBET2 Biosystems Announces First Quarter 2023 Financial Results
23/05/202309:01GLOBET2 Biosystems Announces Exploration of Strategic..
23/05/202309:00GLOBET2 Biosystems Announces FDA 510(k) Submission for the..
22/05/202309:15GLOBET2 Biosystems Reschedules First Quarter 2023 Financial..
17/05/202317:05GLOBET2 Biosystems Reschedules First Quarter 2023 Financial..
15/05/202317:05GLOBET2 Biosystems Postpones Reporting of First Quarter 2023..
01/05/202317:05GLOBET2 Biosystems to Report First Quarter 2023 Financial Results..

Seu Histórico Recente

NASDAQ
TTOO
T2 Biosystems
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados